EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LEF1-AS1 Deregulation in the Peripheral Blood of Patients with Persistent Post-COVID Symptoms

Alisia Madè iD, Santiago Nicolas Piella, Marco Ranucci iD, Carlo Gaetano iD, Laura Valentina Renna iD, Rosanna Cardani, Gaia Spinetti iD, Valentina Milani, Fabio Martelli iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26104806 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Alisia Madè und 8 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Cardiology Laboratory, IRCCS Policlinico San Donato, Via Morandi 30, 20097 San Donato Milanese, Italy. Hauptthemen laut MEDLINE: COVID-19, RNA, Long Noncoding, Lymphoid Enhancer-Binding Factor 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, FMM, Next Generation EU-NRRP M6C2 Inv. 2.1.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long COVID denotes the persistence of symptoms after acute SARS-CoV-2 infection lasting for at least two months without another identifiable cause. Affecting an estimated 15% of COVID-19 patients, long COVID manifests in a wide range of symptoms. Despite extensive research on its one-year effects, limited data exist beyond 12 months. Due to the different manifestations of long COVID, its diagnosis can be challenging. Identifying potential mechanistic contributors and biomarkers would be highly valuable. Recent studies have highlighted the potential of noncoding RNAs (ncRNAs) as biomarkers for disease stratification in COVID-19. Specifically, we have recently identified miR-144-3p and a subset of lncRNAs as candidates for assessing disease severity and outcomes in COVID-19. This nested case–control study extends such investigations to 98 long COVID patients recruited 18 months after hospitalization, exploring the relationship between circulating ncRNA expression and persistent symptoms. While miR-144-3p, HCG18, and lncCEACAM21 expression did not differ between symptomatic and asymptomatic patients, LEF1-AS1 was downregulated in the peripheral blood mononuclear cells (PBMCs) of symptomatic patients. Of note, multiple LEF1-AS1 isoforms and LEF1 sense transcript levels were reduced and negatively correlated with relevant clinical markers. While further studies are needed, our discoveries offer new perspectives on the diagnosis and management of persistent long COVID.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19RNA, Long NoncodingLymphoid Enhancer-Binding Factor 1HumansMaleMiddle AgedCase-Control StudiesFemaleMicroRNAsSARS-CoV-2BiomarkersAgedLeukocytes, MononuclearAdult

Stichwörter der Autor:innen

COVID-19long COVIDlong noncoding RNAsmajor neurological symptomsmajor physical symptomsmicroRNAsnoncoding RNAs

Substanzen

RNA, Long NoncodingMicroRNAsBiomarkersLymphoid Enhancer-Binding Factor 1LEF1 protein, human

Autor:innen und Institutionen

  • Molecular Cardiology Laboratory, IRCCS Policlinico San Donato, Via Morandi 30, 20097 San Donato Milanese, Italy.
  • Department of Cardiovascular Anesthesia and ICU, IRCCS Policlinico San Donato, Via Morandi 30, 20097 San Donato Milanese, Italy.
  • Laboratorio di Epigenetica, Istituti Clinici Scientifici (ICS) Maugeri IRCCS, 27100 Pavia, Italy.
  • BioCor Biobank, IRCCS-Policlinico San Donato, Via Morandi 30, 20097 San Donato Milanese, Italy.
  • Laboratory of Cardiovascular Pathophysiology and Regenerative Medicine, IRCCS MultiMedica, 20138 Milan, Italy.
  • Laboratory of Biostatistics and Data Management, Scientific Directorate, IRCCS Policlinico San Donato, 20097 San Donato Milanese, Italy.

ORCID-Profile: Alisia Madè, Marco Ranucci, Carlo Gaetano, Laura Valentina Renna, Gaia Spinetti, Fabio Martelli

Förderung

  • Ministero della Salute
  • FMM
  • Next Generation EU-NRRP M6C2 Inv. 2.1
  • Ricerca Corrente funding from Italian Ministry of Health to IRCCS Policlinico San Donato
  • Italian Ministry of Health
  • European Union

Zitieren

APA

Madè, A., Piella, S. N., Ranucci, M., Gaetano, C., Renna, L. V., Cardani, R., Spinetti, G., Milani, V., & Martelli, F. (2025). LEF1-AS1 Deregulation in the Peripheral Blood of Patients with Persistent Post-COVID Symptoms. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26104806

Vancouver

Madè A, Piella SN, Ranucci M, Gaetano C, Renna LV, Cardani R, et al. LEF1-AS1 Deregulation in the Peripheral Blood of Patients with Persistent Post-COVID Symptoms. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26104806

BibTeX
@article{Mad2025,
  author = {Madè, Alisia and Piella, Santiago Nicolas and Ranucci, Marco and Gaetano, Carlo and Renna, Laura Valentina and Cardani, Rosanna and Spinetti, Gaia and Milani, Valentina and Martelli, Fabio},
  title = {LEF1-AS1 Deregulation in the Peripheral Blood of Patients with Persistent Post-COVID Symptoms},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26104806}
}
Kostenlos starten →